Bruker (NASDAQ:BRKR) develops and manufactures scientific instruments, analytical systems and related software used to study materials, chemicals, biological samples and industrial products. Its customers include academic and government research institutions, pharmaceutical and biotechnology companies, hospitals, environmental laboratories and industrial manufacturers.
The company’s portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray instruments, microscopy and surface-analysis platforms, molecular spectroscopy systems, and analytical tools for proteomics, spatial biology, metabolomics and materials research. Bruker also provides consumables, software, technical support and other services associated with its instruments.
Bruker was founded in 1960 by Günther Laukien and is headquartered in Billerica, Massachusetts. The company serves customers across North America, Europe, Asia and other international markets. Frank H. Laukien, a member of the founding family, serves as Bruker’s president and chief executive officer.
